R

REGENXBIO

D
RGNX
USD
0.46
(4.3071%)
Market Closed
50,218.00
حجم التداول
-4.83
الربح لكل سهم
-
العائد الربحي
-2.137405
P/E
550,574,314.32
حجم السوق
اليوم
4.3071%
1 اسبوع
-0.447%
1 شهر
9.216%
6 اشهر
-29.494%
12 اشهر
-41.522%
بداية السنة
-37.904%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
REGENXBIO

Sector:
Healthcare
Industry:
Biotechnology
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
هل تحتاج مساعدة او لديك استفسار؟